Related Experiment Video
Updated: Oct 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 27, 2012
Recurrence of atrial fibrillation after switching from brand to generic atenolol
Luca Gallelli1, Francesca Maida1, Orietta Staltari1
1Department of Health Science, University of Catanzaro, Catanzaro, Italy.
Abstract:
Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.
Related Concept Videos
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

